Chemo Pharma Laboratories Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 0.63 | 0.30 | 0.25 |
| Operating Expense | 0.02 | 0.05 | 0.09 |
| Net Profit | 0.61 | 0.25 | -0.29 |
| Net Profit Margin | 96.83 | 83.33 | -116.00 |
| Earning Per Share | 4.07 | 1.64 | -1.94 |
| EBIDTA | 0.61 | 0.25 | -0.02 |
| Effective Tax Rate | TBA | TBA | 180.00 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 0.63 |
| Operating Expense | 0.02 |
| Net Profit | 0.61 |
| Net Profit Margin | 96.83 |
| Earning Per Share | 4.07 |
| EBIDTA | 0.61 |
| Effective Tax Rate | TBA |
Invest in Chemo Pharma Laboratories Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | TBA | TBA | TBA |
| Operating Expenses Annual | 0.19 | 0.21 | 0.41 |
| Operating Profit Annual | 1.65 | 0.09 | 0.38 |
| Interest Annual | TBA | TBA | TBA |
| Depreciation | 0.01 | 0.01 | 0.02 |
| Net Profit Annual | 1.20 | 0.05 | 0.56 |
| Tax Annual | 0.44 | 0.03 | -0.20 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | TBA |
| Operating Expenses Annual | 0.19 |
| Operating Profit Annual | 1.65 |
| Interest Annual | TBA |
| Depreciation | 0.01 |
| Net Profit Annual | 1.20 |
| Tax Annual | 0.44 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.56 | 0.69 | 2.17 |
| Cash Flow from Operations | 0.72 | -0.68 | -0.33 |
| Cash Flow from Investing | -0.52 | 0.63 | 0.97 |
| Cash Flow from Financing | -0.15 | -0.08 | -2.12 |
| Cash Flow at the End | 0.61 | 0.56 | 0.69 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.56 |
| Cash Flow from Operations | 0.72 |
| Cash Flow from Investing | -0.52 |
| Cash Flow from Financing | -0.15 |
| Cash Flow at the End | 0.61 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | TBA | TBA | TBA |
| PBIT Margin (%) | TBA | TBA | TBA |
| PBT Margin (%) | TBA | TBA | TBA |
| Net PROFIT Margin (%) | TBA | TBA | TBA |
| Return On Networth / Equity (%) | 9.84 | 0.43 | 3.37 |
| Return On Networth /Employed (%) | 13.44 | 0.78 | 1.33 |
| Return On Assets (%) | TBA | TBA | TBA |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | TBA | TBA | TBA |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | TBA |
| PBIT Margin (%) | TBA |
| PBT Margin (%) | TBA |
| Net PROFIT Margin (%) | TBA |
| Return On Networth / Equity (%) | 9.84 |
| Return On Networth /Employed (%) | 13.44 |
| Return On Assets (%) | TBA |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 0.02 | 0.03 | 0.04 |
| Total Current Assets Annual | 6.25 | 6.13 | 6.30 |
| Non Current Assets Annual | 6.76 | 5.49 | 5.37 |
| Total Shareholders Funds Annual | 12.80 | 11.60 | 11.55 |
| Total Assets Annual | 13.02 | 11.62 | 11.66 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 0.02 |
| Total Current Assets Annual | 6.25 |
| Non Current Assets Annual | 6.76 |
| Total Shareholders Funds Annual | 12.80 |
| Total Assets Annual | 13.02 |
No Data Availabe
